Author Question: In a DRO procedure, the extinction of maladaptive behavior works best in conjunction with the A) ... (Read 11 times)

lidoalex

  • Hero Member
  • *****
  • Posts: 538
In a DRO procedure, the extinction of maladaptive behavior works best in conjunction with the
 
  A) reinforcement of an alternative behavior.
  B) presentation of a novel stimulus.
  C) elicitation of a conditioned response.
  D) reinforcement of resurgent behavior.

Question 2

Amelie ignores her son when he talks with his mouth full, and she speaks to him when he talks to her after he has finished chewing. This is an example of a _____ procedure.
 
  A) DRP
  B) DRL
  C) DRO
  D) DRH



momo1250

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

A

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

The liver is the only organ that has the ability to regenerate itself after certain types of damage. As much as 25% of the liver can be removed, and it will still regenerate back to its original shape and size. However, the liver cannot regenerate after severe damage caused by alcohol.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library